Published in Gene Therapy Weekly, March 4th, 1996
AD vectors show promise for use in gene therapy protocols, vaccines, and for studying gene functions in differentiated cells. Unfortunately, in spite of their potential usefulness, it is difficult to efficiently obtain the recombinant Ads desired by current methods.
Sanae Miyake et al. modified a promising, but previously unsuccessful process into one that would create recombinant Ads at a rate 100 times as efficient as current methods ("Efficient Generation of Recombinant Adenoviruses Using...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.